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Abstract
Background: Access to medical care in many regions is limited by socioeconomic status, at both the individual and the community level. This report describes the
diagnostic process of a family residing on an underserved Caribbean island where routine neurological care is typically addressed by general practitioners, and genetic
diagnosis is not available through regular medical channels. The diagnosis and management of neurodegenerative disorders is especially challenging in this setting.
Case Report: We diagnosed a family with spinocerebellar ataxia type 3 (SCA3) in an underdeveloped nation with limited access to genetic medicine and no
full-time neurologist.
Discussion: Molecular diagnosis of the SCAs can be challenging, even in developed countries. In the Caribbean, genetic testing is generally only available at a
small number of academic centers. Diagnosis in this family was ultimately made by utilizing an international, pro bono, research-based collaborative process.
Although access to appropriate resources, such as speech, physical, and occupational therapies, is limited on this island because of economic and geographical
factors, the provision of a diagnosis appeared to be ultimately beneficial for this family. Identification of affected families highlights the need for access to genetic
diagnosis in all communities, and can help direct resources where needed.
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Introduction
In developed countries, it is a matter of course that individuals
presenting with ataxia, chorea, dystonia, or tremor have access to a
neurologist, often one specializing in movement disorders. Genetic
diagnostic resources, if required, are generally available to these
patients. In many other parts of the world, however, this standard of
care may not be available or accessible because of a variety of factors,
including geographical isolation or socioeconomic limitations.
There are hundreds of different forms of hereditary ataxia1 and
more than 40 different subtypes of spinocerebellar ataxia (SCA),
each caused by mutation of a different genetic locus.2 The clinical
features of the various SCA types are heterogeneous and may vary consi-
derably, even within the same family. For this reason, genetic diagnosis
of the specific SCA is important for establishing prognosis, genetic
counseling, and potentially treatment.
SCA type 3 (SCA3) is caused by pathogenic expansion of an unstable
CAG trinucleotide repeat in the ATXN3 gene.3 The ages of onset of
several different SCAs appear to be modulated by CAG tract lengths in
various genes, in both the wild-type and expanded alleles.4 The most
consistent clinical manifestation of SCA3 is ataxia, which almost never
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occurs in isolation. Other features of SCA3 reflect progressive cerebellar
and brainstem degeneration, and include dysfunction of oculomotor
systems, pyramidal and extrapyramidal pathways, motor neurons, and
peripheral nerves.5
Over the last 3 years, we have offered an annual pro bono neurology
clinic with a board-certified movement disorders specialist (R.H.W.) on
an island in the West Indies. We request referrals from local physicians
for patients with Parkinson disease, tremor, ataxia, chorea, dystonia,
or any gait disorder not caused by stroke. Coincident with our clinic,
we also provide continuing medical education seminars accredited
by the Caribbean Council of Family Physicians (Jamaica) to help
increase the general understanding of movement disorders in the
community.
Owing to the increased attention from clinicians on this island as a
result of our clinic and seminars, we learned of an extended family
comprising multiple individuals with progressive ataxia. We have
previously described how access to neurological and genetic services is
limited in this region.6
Neurological evaluations were performed (by R.H.W.) at the
patients’ home because of their limited mobility and access to
transportation. Written informed consent was obtained from each
patient for genetic testing and release of clinical and family history.
Owing to the small population size of the countries (less than 100,000
residents) in which these patients reside, our institutional review board
has requested that we do not reveal their precise nationalities or
geographic locations. Consent was not given for publication of video
documentation of the movement disorder. Genetic analysis was
performed pro bono at an academic research laboratory in the USA.
Case report
Individual IV-4. The proband in this family (Figure 1) reported that she
first began noticing gait problems at the age of 19 years. Over the next
6 years, her symptoms progressed, and she sought medical attention
with complaints of dizziness, unsteady gait, and memory and hearing
loss. Brain magnetic resonance imaging (MRI) was obtained and was
reported to be normal. Her symptoms progressively worsened, and
9 years following symptom onset, the patient obtained a second brain
MRI, which showed cerebellar atrophy (Figure 2A). By 13 years after
symptom onset, the patient was unable to walk without support, swallow-
ing was markedly impaired, and she had lost more than 30 pounds
over the previous 6 years. She reported worsening memory problems
and frequent falling. Fourteen years after symptom onset, a third brain
MRI (Figure 2B) revealed increased prominence of the cerebellar folia,
flattening of the pons and medulla, and atrophy of the spinal cord.
Neurological evaluation was performed at 15 years after symptom
onset. The patient had a full range of eye movements, with frequent
small amplitude saccadic intrusions, and nystagmus and overshoot
on smooth pursuit and saccadic gaze. Optokinetic nystagmus (OKN)
was normal. She had intermittent lower facial dystonia with a risus
sardonicus, dystonic posturing of the fingers when the hands were
outstretched, and dystonic flexion of the toes with repetitive move-
ments. Speech was moderately dysarthric. There was moderate
impairment of coordination of both upper and lower extremities, with
mild hypo- and bradykinesia of hand movements. There was moderate
truncal ataxia while sitting. Power was intact throughout, despite
atrophy of hand muscles. The proband exhibited hyper-reflexia of all
Figure 1. Autosomal Dominant Inheritance of SCA3 in a Caribbean Family. Solid symbols indicate affected subjects where family history was certain.
The red arrow indicates the proband, and the black arrows indicate the three patients who were clinically examined. Intermediate symbols indicate individuals who
are possibly affected based on family history. Age of onset and the number of CAG repeats in the ATXN1 gene are indicated.
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four limbs, with no Babinski sign. The vibration sensation was
moderately impaired in all four limbs; however, sensory modalities
were intact. She could only stand and walk with support. Gait was
markedly wide-based, with dystonic plantar flexion of the feet on
stepping. During this visit, the patient scored 21 on the Scale for
Assessment and Rating of Ataxia (SARA; maximum 5 40). Genetic
testing showed a pathogenic expansion of 77 CAG repeats on one
allele of the ATXN3 gene and 22 repeats on the other.
Individual III-6. The 53-year-old mother of the proband reported that
she developed gait difficulties at approximately 37 years of age. She is
now unable to walk without support and she notes that her head shakes
when she is tired or hungry. On examination, speech was moderately
dysarthric and occasionally difficult to understand. In primary gaze,
she had marked macrosaccadic jerks. The full range of eye movements
was present; however, smooth pursuit and saccadic gaze both showed
significant saccadic intrusions, and impairment of OKN was observed.
Power was intact throughout, apart from mild weakness of wrist flexion
and extension, and of finger abduction. Deep tendon reflexes were
pathologically brisk in both arms and knees, and absent at the ankles.
There was no Babinski sign. Coordination was mildly impaired in both
arms and moderately impaired in both legs. Vibration sense was
moderately impaired at both ankles, but intact in the upper limbs.
Proprioception, pinprick, and light touch were normal. She could
stand and walk with a little support, but was very unsteady, and gait
was markedly wide-based. Her SARA score was 18. Genetic testing
showed CAG repeats of 73 and 22 in ATXN3.
Individual IV-7. The 29-year-old sister of the proband first noticed gait
problems at the age of 24 years. She continued to work without
problems, but noted mild impairment of speech, swallowing, and
balance. She had lost several pounds since disease onset, and reported
occasional, variable double vision. On examination, her speech was
very mildly dysarthric. There were moderate macrosaccadic intrusions
in the mid-position. There was nystagmus on smooth pursuit and
saccadic gaze, with overshoot. Power was intact throughout. Deep
tendon reflexes were brisk with distal spread. Ankle jerks were also
brisk with two or three beats of clonus bilaterally. The Babinski sign
was present on the left. There was mild impairment of vibration in all
four limbs, but other modalities were intact. She had very mild
impairment of coordination of all limbs, which was more marked
on the left. Gait was mildly wide-based, with unsteadiness on turning
and tandem gait. She swayed in the Romberg position. Her SARA
score was 6.5, and genetic testing showed 75 and 22 CAG repeats in
ATXN3.
Other family members. During our interviews with members of this
family, we were told that other affected members exist; however, we
were unable to establish contact with these individuals. Despite
apparent geographic proximity, communication between inhabitants
of neighboring villages is sometimes minimal because of various
factors, including transportation and technological infrastructure
limitations. This is further compounded for individuals affected by
neurodegenerative disorders. It was also reported that affected indi-
viduals had moved to other countries such as Trinidad, Barbados,
the USA, or the UK, and that contact had been lost. Currently, it is
unknown if any of these other family members have been diagnosed
with an ataxic disorder.
Discussion
Access to resources for genetic diagnosis varies greatly both
within and between countries. In some countries, diagnostic genetic
testing, at least for relatively well-recognized disorders, is readily
accessible, while in others it is effectively impossible to perform.
Figure 2. Brain Magnetic Resonance Imaging of Patient IV-4 Shows Progressive Cerebellar Degeneration and Atrophy of the Medulla, Pons,
and Brainstem. (A) Nine years after symptom onset. (B) Fourteen years after symptom onset.
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(Documentation of access to genetic testing resources is a current
project of the Rare Diseases Study Group of the International Parkinson
Disease and Movement Disorders Society, via an electronic survey of
Society members.)
The community in which this family resides is underserved and
neurological specialty services are not available. Typically, people with
neurological conditions are seen by family practice physicians, or
referred to an internist if in hospital. Genetic diagnosis is generally
unavailable for a variety of reasons, including lack of local services and
low socioeconomic status. To date, all molecular diagnostic investiga-
tions performed have been carried out by the senior author (A.K.S.) in
collaboration with local clinicians and medical students as extra-
curricular academic activities.6,7 The informal process leading to the
diagnosis was initiated when the proband sought medical attention
from her primary care physician, who was aware of the research
interests of the senior author.
Most genetic testing in this region occurs in academic centers in
Cuba or Puerto Rico; however, even in these countries, it is more
limited than in developed nations. Although West Indian nations
are currently attempting to build capacity for genetic testing,8
overall, this type of service is lacking.9,10 To our knowledge, ours is
only the second report of SCA3 in this region, the first being by
Gwinn-Hardy et al.,11 who described genetic diagnosis of SCA3 in a
family residing in the UK and USA following immigration from
Antigua. Apart from a cluster of families with SCA2 documented
in the Holguin province of Cuba12–14 and a cluster of families on
Martinique,15,16 there have not been any other reports of any of the
SCAs in the Caribbean region.
The correct identification of the disorder allowed patients in this
family to understand the implications for themselves and their offspr-
ing, and put a label to their symptoms. Advice about physical exercise
and nutrition was offered as the best way to delay symptom pro-
gression;14 however, access to formal physical, speech, and nutritional
therapy resources is limited by both geographical and economic
factors. Owing to geographical isolation, it would be difficult to recruit
these patients into any research study of SCA3, and even remote care
using electronic communication is compromised by the limited tech-
nological resources on the island.
The patients we characterized in this study demonstrate the pheno-
mena of anticipation17 wherein age of onset and disorder severity
correlate with expansion of the triplet repeat. Table 1 compares the
onset age to the triplet repeat expansion and each measured item on
the SARA scale. As shown in Table 1, patients who have a larger
number in repeats in ATXN3 have an earlier age of onset and more
severe symptoms than patients with fewer repeats in the gene.
This case report highlights a cultural block to the attainment of
diagnosis. Although it was well known within the family that members
across several generations were affected by a disease, only one family
member, who was well-educated, sought medical attention. She
received the non-specific diagnosis of ataxia; involvement of a move-
ment disorders specialist and collaboration with an international
research laboratory allowed us to definitively diagnose the condition
and facilitate genetic counseling. The identification of the genetic
cause for the familial disorder appeared, in general, to be reassuring
to the affected family members and allowed us to confidently educate
the patients about autosomal dominant inheritance. However, it was
apparent that the lack of effective treatments was a source of frustra-
tion for subject IV-7, who started researching ‘‘stem cell therapies’’.
As a result of this case, and several others that we are currently
investigating, we have garnered the interest of several local physicians
and are currently making the case for the creation of a national registry
for patients who have neurological degeneration or movement dis-
orders. Owing to geographical isolation, it would be difficult to recruit
these patients into a clinical trial for SCA3; technological limitations
make eHealth impractical. Ancillary services such as physical therapy,
speech therapy, and nutrition therapy exist to a limited degree;
however, these families reside at large distances from where the
services are offered, and do not have the means to travel. The purpose
of this paper is to highlight these needs. We continue to support these
patients with pro bono movement disorder consultations. Without our
outreach program, these patients would not have access to this level of
specialty medical services.
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